Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients

The receptor activator of NF-κB (RANK) pathway is involved in bone health as well as breast cancer (BC) pathogenesis and progression. Whereas the therapeutic implication of this pathway is established for the treatment of osteoporosis and bone metastases, the application in adjuvant BC is currently...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hein, Alexander, Bayer, Christian M., Schrauder, Michael G., Häberle, Lothar, Heusinger, Katharina, Strick, Reiner, Ruebner, Matthias, Lux, Michael P., Renner, Stefan P., Schulz-Wendtland, Rüdiger, Ekici, Arif B., Hartmann, Arndt, Beckmann, Matthias W., Fasching, Peter A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi Publishing Corporation 2014
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963378/
https://ncbi.nlm.nih.gov/pubmed/24729980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/842452
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg